Logo image of ALESE.PA

ENTECH SACA (ALESE.PA) Stock Fundamental Analysis

EPA:ALESE - Euronext Paris - Matif - FR0014004362 - Common Stock - Currency: EUR

8.34  +1.12 (+15.51%)

Fundamental Rating

4

ALESE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 48 industry peers in the Construction & Engineering industry. While ALESE has a great health rating, there are worries on its profitability. ALESE is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALESE had negative earnings in the past year.
In the past year ALESE had a positive cash flow from operations.
ALESE had negative earnings in 4 of the past 5 years.
In the past 5 years ALESE always reported negative operating cash flow.
ALESE.PA Yearly Net Income VS EBIT VS OCF VS FCFALESE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

ALESE has a Return On Assets of -5.81%. This is amonst the worse of the industry: ALESE underperforms 89.58% of its industry peers.
ALESE has a worse Return On Equity (-11.36%) than 89.58% of its industry peers.
Industry RankSector Rank
ROA -5.81%
ROE -11.36%
ROIC N/A
ROA(3y)-2.34%
ROA(5y)-0.87%
ROE(3y)-4.85%
ROE(5y)-2.97%
ROIC(3y)N/A
ROIC(5y)N/A
ALESE.PA Yearly ROA, ROE, ROICALESE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ALESE has a Gross Margin of 42.82%. This is in the better half of the industry: ALESE outperforms 60.42% of its industry peers.
ALESE's Gross Margin has declined in the last couple of years.
ALESE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5YN/A
ALESE.PA Yearly Profit, Operating, Gross MarginsALESE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

ALESE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALESE remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ALESE has a worse debt to assets ratio.
ALESE.PA Yearly Shares OutstandingALESE.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
ALESE.PA Yearly Total Debt VS Total AssetsALESE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 4.15 indicates that ALESE is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALESE (4.15) is better than 89.58% of its industry peers.
ALESE has a debt to FCF ratio of 1.00. This is a very positive value and a sign of high solvency as it would only need 1.00 years to pay back of all of its debts.
ALESE has a Debt to FCF ratio of 1.00. This is amongst the best in the industry. ALESE outperforms 89.58% of its industry peers.
ALESE has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
ALESE's Debt to Equity ratio of 0.08 is amongst the best of the industry. ALESE outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1
Altman-Z 4.15
ROIC/WACCN/A
WACC7.51%
ALESE.PA Yearly LT Debt VS Equity VS FCFALESE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.94 indicates that ALESE should not have too much problems paying its short term obligations.
ALESE has a better Current ratio (1.94) than 85.42% of its industry peers.
A Quick Ratio of 1.81 indicates that ALESE should not have too much problems paying its short term obligations.
The Quick ratio of ALESE (1.81) is better than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.81
ALESE.PA Yearly Current Assets VS Current LiabilitesALESE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

ALESE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -294.30%.
ALESE shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.45%.
ALESE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.95% yearly.
EPS 1Y (TTM)-294.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.33%
Revenue 1Y (TTM)32.45%
Revenue growth 3Y68.95%
Revenue growth 5YN/A
Sales Q2Q%43.81%

3.2 Future

ALESE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 116.80% yearly.
Based on estimates for the next years, ALESE will show a very strong growth in Revenue. The Revenue will grow by 38.17% on average per year.
EPS Next Y166.67%
EPS Next 2Y154.48%
EPS Next 3Y116.8%
EPS Next 5YN/A
Revenue Next Year42.47%
Revenue Next 2Y51.97%
Revenue Next 3Y42.05%
Revenue Next 5Y38.17%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALESE.PA Yearly Revenue VS EstimatesALESE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
ALESE.PA Yearly EPS VS EstimatesALESE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALESE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 17.23 indicates a rather expensive valuation of ALESE.
ALESE's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALESE is more expensive than 62.50% of the companies in the same industry.
ALESE is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.36, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 17.23
ALESE.PA Price Earnings VS Forward Price EarningsALESE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALESE is valued a bit cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.87
EV/EBITDA N/A
ALESE.PA Per share dataALESE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ALESE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALESE's earnings are expected to grow with 116.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y154.48%
EPS Next 3Y116.8%

More info and screens

0

5. Dividend

5.1 Amount

ALESE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENTECH SACA

EPA:ALESE (8/6/2025, 7:00:00 PM)

8.34

+1.12 (+15.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners11.98%
Inst Owner ChangeN/A
Ins Owners63.72%
Ins Owner ChangeN/A
Market Cap122.43M
Analysts86
Price Target11.37 (36.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.23
P/S 2.69
P/FCF 8.87
P/OCF 7.91
P/B 4.76
P/tB 6.18
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)0.48
Fwd EY5.8%
FCF(TTM)0.94
FCFY11.28%
OCF(TTM)1.05
OCFY12.64%
SpS3.1
BVpS1.75
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.81%
ROE -11.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.82%
FCFM 30.37%
ROA(3y)-2.34%
ROA(5y)-0.87%
ROE(3y)-4.85%
ROE(5y)-2.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1
Debt/EBITDA N/A
Cap/Depr 226.86%
Cap/Sales 3.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.81
Altman-Z 4.15
F-Score4
WACC7.51%
ROIC/WACCN/A
Cap/Depr(3y)285.26%
Cap/Depr(5y)212.15%
Cap/Sales(3y)7.1%
Cap/Sales(5y)9.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-294.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.33%
EPS Next Y166.67%
EPS Next 2Y154.48%
EPS Next 3Y116.8%
EPS Next 5YN/A
Revenue 1Y (TTM)32.45%
Revenue growth 3Y68.95%
Revenue growth 5YN/A
Sales Q2Q%43.81%
Revenue Next Year42.47%
Revenue Next 2Y51.97%
Revenue Next 3Y42.05%
Revenue Next 5Y38.17%
EBIT growth 1Y-189.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year317.14%
EBIT Next 3Y118.68%
EBIT Next 5Y103.56%
FCF growth 1Y236.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y273.44%
OCF growth 3YN/A
OCF growth 5YN/A